Atlas Trials

Extended Dose Intervals With Oral Cholera Vaccine in Cameroon

Clinical trial NCT03719066 · COMPLETED

Trial details

NCT number
NCT03719066
Sponsor
Johns Hopkins Bloomberg School of Public Health
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Adverse Reaction to Cholera VaccineCholera Vaccination Reaction
Start date
2018-10-23
Primary completion
2020-02-27
Enrollment
181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.